Your institution may have access to this item. Find your institution then sign in to continue.
Title
Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alpha-2a plus ribavirin.
Authors
Bain, V G; Lee, S S; Peltekian, K; Yoshida, E M; Deschênes, M; Sherman, M; Bailey, R; Witt-Sullivan, H; Balshaw, R; Krajden, M; Canadian PEGASYS Study Group
Abstract
The impact of reduced drug exposure on outcomes in patients with chronic hepatitis C has not been determined in routine clinical practice.